CMS: Hospital Readmissions Down to 17.8%

Yesterday, CMS said President Barack Obama’s 2010 healthcare law, the Patient Protection and Affordable Care Act has contributed to a significant drop in hospital readmissions for Medicare patients.

Advertisement

Jonathan Blum, deputy administrator director of CMS, released the new figures at a Senate Finance Committee hearing yesterday, saying the law has already made “significant progress” in improving the U.S. health system.

Hospital readmissions for Medicare patients have declined by more than 1 percent in the short time the law has been active. CMS said the 30-day, all-cause readmission rate dropped from 19 percent over the past five years to 17.8 percent, as of November 2012 — or roughly 70,000 fewer readmissions in 2012.

CMS also cited its most recent national healthcare expenditures report, which said health spending grew only 3.9 percent in 2011 — the third straight year of historically slow growth. Total expenditures hit $2.7 trillion, but Medicare spending per beneficiary only grew 0.4 percent.

CMS credited the figures to several measures of the PPACA, including the Readmission Reduction Program, the Hospital Value-Based Purchasing Program and other initiatives that have spurred the development of accountable care organizations and shared-savings models.

More Articles on Hospital Readmissions:

Study: Medicare, Medicaid Patients More Likely to Have “Bounce-Back” Admissions After ED Discharge
Study: All-Cause Readmissions Yield Artificially High Rates
Why Improving Communication May Be the Key to Reducing Readmissions

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Clinical Leadership & Infection Control

Advertisement

Comments are closed.